Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Azerbaijan shares Great Return experience with SyriaMourinho Signs Contract with Real MadridMoscow heatwave breaks 129-year recordPoland stocks higher: WIG30 up 1.47%Real chocolate makes a comebackBoE's Bailey: Time to gauge Iran war impact on ratesWhy is KLA stock surging today?Amazon Wins Tariff Evasion AppealAMPCO Pittsburgh CEO buys $29,791 in stockArcos Dorados Q1 2026 Beats EPS ForecastsAzerbaijan shares Great Return experience with SyriaMourinho Signs Contract with Real MadridMoscow heatwave breaks 129-year recordPoland stocks higher: WIG30 up 1.47%Real chocolate makes a comebackBoE's Bailey: Time to gauge Iran war impact on ratesWhy is KLA stock surging today?Amazon Wins Tariff Evasion AppealAMPCO Pittsburgh CEO buys $29,791 in stockArcos Dorados Q1 2026 Beats EPS Forecasts
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#design-therapeutics

Latest news and interesting information about design-therapeutics.

DT-216P2 Shows Promise in Friedreich Ataxia Trial
2026-05-18 11:41
|
776

DT-216P2 Shows Promise in Friedreich Ataxia Trial

Design Therapeutics announces positive Phase 1/2 trial data for DT-216P2 in Friedreich ataxia, showing clinical improvements and good tolerability.

SEC FILINGS →
0
...